Colgate-Palmolive Company (CL) Likely to Report ~In Line Ahead of Difficult Comps - RBC Capital

February 2, 2021 6:34 AM EST
Get Alerts CL Hot Sheet
Price: $79.78 +0.18%

Rating Summary:
    10 Buy, 15 Hold, 4 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 42
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

RBC Capital analyst Nik Modi reiterated a Sector Perform rating and $226.00 price target on Colgate-Palmolive Company (NYSE: CL) forecasting organic growth of +19.1% vs. consensus +20% and EPS of $1.76 vs. consensus $1.77.

The analayst stated "After conducting our channel checks, we believe organic growth of 20–24% is achievable. We believe the topline will remain strong in the upcoming quarter due to continued
delays in vaccination distribution and rising case counts. However, investor focus will likely remain on upcoming difficult comps and inflationary pressures."

For an analyst ratings summary and ratings history on Colgate-Palmolive Company click here. For more ratings news on Colgate-Palmolive Company click here.

Shares of Colgate-Palmolive Company closed at $78.52 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments

Related Entities

RBC Capital